Vaginal capsule plus antibiotic for bacterial vaginosis
Part of Infections, Women’s health & pregnancy clinical trials.
This trial tests a new vaginal capsule called BPR-101, given together with the antibiotic metronidazole, to treat bacterial vaginosis (BV). If you have BV, this study aims to see if the combination is safe and effective in clearing the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 50 and have been sexually active
- You have a confirmed diagnosis of bacterial vaginosis (BV) based on specific lab tests
- You are willing to use a vaginal capsule and avoid other vaginal products (like tampons or douches) during the study
- You can agree not to take certain other medicines or probiotics before or during the trial
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You do not have other vaginal or pelvic infections (like yeast infections or sexually transmitted infections)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaginal treatment for bacterial vaginosis (BV), a common infection causing itching, odor, and discharge. It aims to see if the treatment is safe and works well.
This study tests two new investigational drugs to treat bacterial vaginosis. It aims to see if these drugs are safe and work well. If you have BV, this trial could give you access to a new treatment option.
This study tests whether adding probiotics to standard care helps treat bacterial vaginosis (BV) and possibly lowers the chance of it coming back. You would be placed into a study group to compare probiotic treatment with the other approach.
This study tests whether a vaginal probiotic called Gyntima Balance can help prevent bacterial vaginosis from coming back. If you have had repeat infections, this might be a way to reduce future episodes.
This study tests a vaginal ovule (a small tablet inserted into the vagina) to see if it safely treats two common vaginal infections: bacterial vaginosis and yeast infections (candidiasis). It may help relieve symptoms like discharge, itching, and burning.
This study tests a new medicine, given as a single vaginal dose, in healthy women. It is one of the first studies in humans, so the main goal is to see if the medicine is safe and how the body handles it.
Hear when a new Bacterial Vaginosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.